FGFR2 and squamous cell lung carcinoma: Liao and colleagues reported in 2013 the identification of inhibitor-sensitive oncogenic FGFR2 and FGFR3 mutations in lung squamous cell carcinoma from the Cancer Genome Atlas (TCGA) dataset [12].